Bronchitic and non-bronchitic phenotypes of COPD differ in the prevalence of depressive symptoms

V. Koblizek, S. Pracharova, M. Hronek, M. Kovarik (Hradec Kralove, Czech Republic)

Source: Annual Congress 2012 - COPD comorbidities II
Session: COPD comorbidities II
Session type: Thematic Poster Session
Number: 544
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Koblizek, S. Pracharova, M. Hronek, M. Kovarik (Hradec Kralove, Czech Republic). Bronchitic and non-bronchitic phenotypes of COPD differ in the prevalence of depressive symptoms. Eur Respir J 2012; 40: Suppl. 56, 544

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High prevalence of current smokers among COPD patients with anxiety and depression symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 193s
Year: 2001

Changes in prevalence and severity of asthma and respiratory symptoms with age in children
Source: Eur Respir J 2002; 20: Suppl. 38, 316s
Year: 2002

The prevelance of chronic nasal symptoms in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002

Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
Source: Eur Respir J 2002; 19: 202
Year: 2002


GERD and anxiety in patients with severe COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Depressive symptoms in asthma patients
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012


The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations
Source: Eur Respir J 2013; 41: 815-823
Year: 2013



Prevalence of work-aggravated symptoms in clinically established asthma
Source: Eur Respir J 2003; 22: 305-309
Year: 2003



The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Impact of exacerbation of COPD on anxiety and depression symptoms and dyspnea in the activities of daily living
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015

COPD and depression
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012

Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
Source: Eur Respir J 2001; 17: 596-603
Year: 2001



Sex differences in asthma-like symptoms and doctor diagnosed asthma versus parameters of lower airway inflammation among adolescents
Source: Eur Respir J 2001; 18: Suppl. 33, 374s
Year: 2001

Frequency of depressive syndrome in patients with bronchial asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021

Gender-specific differences in symptoms among patients with severe COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Prevalence and impact of depression on COPD
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Different features between subjects with asthma diagnosis and with only asthmatic symptoms
Source: Annual Congress 2010 - Methods in respiratory epidemiology
Year: 2010

Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021